Colgate-Palmolive (NYSE:CL) Earns “Hold” Rating from TD Cowen

Colgate-Palmolive (NYSE:CL)‘s stock had its “hold” rating reiterated by stock analysts at TD Cowen in a research report issued on Tuesday, Marketbeat.com reports. They currently have a $85.00 target price on the stock. TD Cowen’s price objective suggests a potential downside of 0.69% from the stock’s previous close.

Other analysts also recently issued research reports about the stock. Argus reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Barclays boosted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. The Goldman Sachs Group reissued a “buy” rating and issued a $100.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 20th. UBS Group lifted their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a report on Wednesday, January 14th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the stock from $90.00 to $98.00 in a research report on Monday. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.19.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $85.59 on Tuesday. The business’s fifty day moving average price is $91.13 and its 200 day moving average price is $83.39. Colgate-Palmolive has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The stock has a market capitalization of $68.67 billion, a P/E ratio of 32.67, a PEG ratio of 3.78 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 earnings per share. As a group, research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. The trade was a 63.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of CL. Kemnay Advisory Services Inc. acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $25,000. CBIZ Investment Advisory Services LLC increased its position in shares of Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares during the last quarter. TD Capital Management LLC raised its stake in shares of Colgate-Palmolive by 61.4% in the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after purchasing an additional 124 shares in the last quarter. Triumph Capital Management lifted its position in shares of Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after purchasing an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc acquired a new position in Colgate-Palmolive in the fourth quarter worth about $26,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.